ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Noxopharm Files Septic Shock Treatment Patent for Veyonda®
April 15, 2021Australian clinical-stage drug development company Noxopharm Limited announced an international patent application aimed at protecting the use of experimental anti-cancer drug, Veyonda® (idronoxil), in blocking the development of septic shock ... -
Vivacelle Bio Receives Award from Navy for VBI-S Trial for Hypovolemia of Septic Shock Due to COVID
December 10, 2020Vivacelle Bio announces the Department of Defense awarded $5.3 million dollars for the clinical trial of VBI-S, an intravenously injected fluid based upon Vivacelle Bio's phospholipid nanoparticle technology for the treatment of septic shock due to ...
Pharma Sources Insight January 2025
